-
-
-
-
-
-
-
Mynd Announces 2024 First Half Results
-
-
-
-
-
-
-
MYND Life Sciences Acquires Rights for the Use of Psychedelics to Treat Alzheimer's Disease and other Dementias
-
-
-
-
-
-
-
Emmaus Life Sciences Completes Merger
-
-
-
-
-
-
-
MYnd Analytics Provides Business and Merger Updates
-
-
-
-
-
-
-
MYnd Analytics Awarded European Patent on Neuromodulation Platform; Predicts Patients Likely to Respond to TMS for Treating Depression
-
-
-
-
-
-
-
Pre-Open Stock Movers 01/07: (LXFT) (LOXO) (SAGE) Higher; (PCG) (NHTC) (DXC) Lower (more...)
-
-
-
-
-
-
1,188,136 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

